An observational study in Intracranial Aneurysm, Anterior Communicating Artery Aneurysm and Cerebral Aneurysm, sponsored by Hospital Clinic of Barcelona. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-05-15.
Sponsored by Hospital Clinic of Barcelona · Observational
Based on the anatomical features of the anterior Communicating artery complex, the investigators will analyze the outcome of the ACoA aneurysms treated by endovascular therapy.
The most common site of intracranial aneurysms is the anterior communicating artery (AcomA). AcomA aneurysms account for approximately one-fourth of all intracranial aneurysms.
Recent publications have addressed specifically the endovascular treatment of AcoA aneurysms. Furthermore, detailed anatomic characteristics and the effects of the multiple variations of the anterior communicating artery complex have scarcely been reported.
The hemodynamic factors play a fundamental role in the adequate treatment of aneurismal coiling.
The objective of our registry is to analyze the impact of morphological configuration of the anterior communicating artery complex and the results of coil embolization in AcoA aneurysms
Patients with Communicating Artery Aneurysm treated with endovascular coiling.
Exclusion Criteria:
Effective Aneurysm Coiling (no residual cerebral aneurysm)
Time frame: 1 year
All Cause Mortality
Time frame: 1 year
Neurological Outcome (classified with the Glasgow Outcome Scale, Rankin Scale)
All patients will be classified with the Glasgow Outcome Scale, Rankin Scale.
Time frame: 1 year
Procedural device-related serious adverse events
Time frame: 1 year
This study is status unknown, as verified in May 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Clinic of Barcelona